Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

Clinical trial NCT06796998 · RECRUITING

Trial details

NCT number: NCT06796998
Sponsor: Izidore Lossos, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Marginal Zone Lymphoma Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Splenic Marginal Zone Lymphoma Nodal Marginal Zone Lymphoma

Start date: 2025-10-13
Primary completion: 2028-10-15
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.